Vorinostat

( DrugBank: Vorinostat / KEGG DRUG: Vorinostat )

2 diseases

ID	Disease name (Link within this page)	Number of trials
75	Cushing disease	1

ID	Disease name (Link within this page)	Number of trials
96	Crohn disease	1

75. Cushing disease

Clinical trials : 205 / Drugs : 176 - (DrugBank : 45) / Drug target genes : 61 - Drug target pathways : 127

trials per page:

Showing 1 to 1 of 1 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04339751 (ClinicalTrials.gov)	March 22, 2023	8/4/2020	Effect of Vorinostat on ACTH Producing Pituitary Adenomas in Cushing s Disease	The Effect of Vorinostat on ACTH Producing Pituitary Adenomas in Cushing's Disease	Cushing's Disease	Drug: Vorinostat	National Institute of Neurological Disorders and Stroke (NINDS)	NULL	Recruiting	18 Years	N/A	All	22	Phase 2	United States

Clinical trials : 2,442 / Drugs : 1,278 - (DrugBank : 248) / Drug target genes : 142 - Drug target pathways : 209

trials per page:

Showing 1 to 1 of 1 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03167437 (ClinicalTrials.gov)	October 30, 2017	24/5/2017	An Open-Label, Proof of Consent Study of Vorinostatfor the Treatment of Mdoerate-to-Severe Crohn s D ...	An Open-Label, Proof of Concept Study of Vorinostatfor the Treatment of Moderate-to-Severe Crohn's D ...	Crohn's Disease	Drug: Vorinostat;Drug: Ustekinumab	National Institute of Allergy and Infectious Diseases (NIAID)	NULL	Recruiting	18 Years	65 Years	All	35	Phase 1/Phase 2	United States